Zibotentan in microvascular angina: a randomized, placebo-controlled, crossover trial

1 September 2024 (14:30 - 14:40)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Andrew Morrow

BHF Glasgow Cardiovascular Research Centre, Glasgow (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail

Inhibition of ceramide de novo synthesis mitigates atherosclerosis

Miss S. Chong (Singapore, SG)

Abstract Slides Video

Presentation thumbnail

Experimental evidence on colchicine's mode of action in human carotid artery plaques

Mrs I. Steenbuck (Freiburg, DE)

Abstract Slides Video

Presentation thumbnail

The short-term prognosis of salvianolate use during hospitalization in patients with acute myocardial infarction

Doctor R. Guo (Tianjin, CN)

Abstract Slides Video

Presentation thumbnail

Safety, tolerability, and basic pharmacokinetic parameters of AUX-001, a once-daily extended release nicorandil in healthy volunteers under fasting and fed conditions

Doctor U. Tigoer (Saratoga Springs, US)

Abstract Slides Video

Presentation thumbnail

SHR-1918, a monoclonal antibody against angiopoietin-like 3, in healthy subjects: a randomized, double-blind, placebo-controlled, phase 1 study

Mr C. Lv (Shanghai, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Novel drugs for cardiovascular diseases

The Event

Event poster

ESC Congress 2024

1 September 2024 14:30 CET

You may be interested in

Congress Session

Novel drugs for cardiovascular diseases

Congress Presentation

Design and rationale of the efficacy of endothelin receptor antagonism in treatment of coronary artery spasm: a randomized controlled trial (EDIT-CAS).

Congress Session

Late-Breaking Clinical Trials: cardiovascular risk and prevention

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources